What Happened?
Cambridge, MA-based Sigilon Therapeutics Appointed Hozefa Bandukwala as Vice President of Platform Innovation
About the Company
Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases. We're based in Cambridge, Mass.
About the Person
Hozefa Bandukwala is Vice President of Platform Innovation at Sigilon Therapeutics. Previously, Hozefa held various senior IT leadership roles in the industry.
Info Source
News
Short Profile